Bluejay Diagnostics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $-2.9M | $96.0K |
| Mar 2020 | — | $-3.3M | — |
| Jun 2020 | — | $-3.6M | — |
| Sep 2020 | — | $-3.7M | — |
| Dec 2020 | — | $-4.2M | $912.4K |
| Mar 2021 | — | $-4.3M | — |
| Jun 2021 | — | $123.5K | — |
| Sep 2021 | — | $-1.1M | $2.3M |
| Dec 2021 | — | $20.4M | $19.0M |
| Mar 2022 | — | $18.5M | $17.1M |
| Jun 2022 | — | $16.7M | $15.3M |
| Sep 2022 | — | $13.8M | $13.3M |
| Dec 2022 | — | $11.5M | $10.1M |
| Mar 2023 | — | $9.2M | $6.8M |
| Jun 2023 | — | $6.4M | $5.1M |
| Sep 2023 | — | $5.2M | $5.1M |
| Dec 2023 | — | $2.9M | $2.2M |
| Mar 2024 | — | $3.4M | $2.7M |
| Jun 2024 | — | $8.6M | $8.1M |
| Sep 2024 | — | $7.2M | $5.8M |
| Dec 2024 | — | $5.7M | $4.3M |
| Mar 2025 | — | $3.9M | $3.1M |
| Jun 2025 | — | $5.3M | $4.4M |
| Sep 2025 | — | $3.7M | $3.1M |
| Dec 2025 | — | $6.0M | $5.2M |
| Mar 2026 | — | $4.2M | $3.7M |
| Jun 2026 | — | $9.4M | $9.6M |